Press Releases

APCER Report Confirms Endari ® SafetyApril 27, 2020

Emmaus announced today that APCER Life Sciences (APCER) has confirmed the safety profile of Endari®, Emmaus’ prescription grade L-glutamine oral powder for the treatment of sickle cell disease.

Read More